FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384201712> ?p ?o ?g. }

• W4384201712 endingPage "3595" @default.
• W4384201712 startingPage "3595" @default.
• W4384201712 abstract "Given the dismal prognosis of small cell lung cancer (SCLC), novel therapeutic targets are urgently needed. We aimed to evaluate whether SSTR expression, as assessed by positron emission tomography (PET), can be applied as a prognostic image biomarker and determined subjects eligible for peptide receptor radionuclide therapy (PRRT).A total of 67 patients (26 females; age, 41-80 years) with advanced SCLC underwent SSTR-directed PET/computed tomography (somatostatin receptor imaging, SRI). SRI-avid tumor burden was quantified by maximum standardized uptake values (SUVmax) and tumor-to-liver ratios (T/L) of the most intense SCLC lesion. Scan findings were correlated with progression-free (PFS) and overall survival (OS). In addition, subjects eligible for SSTR-directed radioligand therapy were identified, and treatment outcome and toxicity profile were recorded.On a patient basis, 36/67 (53.7%) subjects presented with mainly SSTR-positive SCLC lesions (>50% lesions positive); in 10/67 patients (14.9%), all lesions were positive. The median SUVmax was found to be 8.5, while the median T/L was 1.12. SRI-uptake was not associated with PFS or OS, respectively (SUVmax vs. PFS, ρ = 0.13 with p = 0.30 and vs. OS, ρ = 0.00 with p = 0.97; T/L vs. PFS, ρ = 0.07 with p = 0.58 and vs. OS, ρ = -0.05 with p = 0.70). PRRT was performed in 14 patients. One patient succumbed to treatment-independent infectious complications immediately after PRRT. In the remaining 13 subjects, disease control was achieved in 5/13 (38.5%) with a single patient achieving a partial response (stable disease in the remainder). In the sub-group of responding patients, PFS and OS were 357 days and 480 days, respectively.SSTR expression as detected by SRI is not predictive of outcome in patients with advanced SCLC. However, it might serve as a therapeutic target in selected patients." @default.
• W4384201712 created "2023-07-14" @default.
• W4384201712 creator A5016440729 @default.
• W4384201712 creator A5021273661 @default.
• W4384201712 creator A5022354072 @default.
• W4384201712 creator A5031324764 @default.
• W4384201712 creator A5045268154 @default.
• W4384201712 creator A5045592295 @default.
• W4384201712 creator A5046324935 @default.
• W4384201712 creator A5046960472 @default.
• W4384201712 creator A5057320214 @default.
• W4384201712 creator A5060665831 @default.
• W4384201712 creator A5061315225 @default.
• W4384201712 creator A5067397275 @default.
• W4384201712 creator A5075903251 @default.
• W4384201712 creator A5088874257 @default.
• W4384201712 creator A5090220659 @default.
• W4384201712 date "2023-07-13" @default.
• W4384201712 modified "2023-09-27" @default.
• W4384201712 title "In-Vivo Somatostatin-Receptor Expression in Small Cell Lung Cancer as a Prognostic Image Biomarker and Therapeutic Target" @default.
• W4384201712 cites W2039076228 @default.
• W4384201712 cites W2044234433 @default.
• W4384201712 cites W2047544421 @default.
• W4384201712 cites W2048420147 @default.
• W4384201712 cites W2056631765 @default.
• W4384201712 cites W2090257199 @default.
• W4384201712 cites W2094581962 @default.
• W4384201712 cites W2158127925 @default.
• W4384201712 cites W2296714984 @default.
• W4384201712 cites W2622435004 @default.
• W4384201712 cites W2752482655 @default.
• W4384201712 cites W2805387445 @default.
• W4384201712 cites W2893960509 @default.
• W4384201712 cites W2924311564 @default.
• W4384201712 cites W2972777205 @default.
• W4384201712 cites W3003747453 @default.
• W4384201712 cites W3040054525 @default.
• W4384201712 cites W3155388144 @default.
• W4384201712 cites W3199068224 @default.
• W4384201712 cites W3200211049 @default.
• W4384201712 cites W4206899631 @default.
• W4384201712 doi "https://doi.org/10.3390/cancers15143595" @default.
• W4384201712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37509258" @default.
• W4384201712 hasPublicationYear "2023" @default.
• W4384201712 type Work @default.
• W4384201712 citedByCount "0" @default.
• W4384201712 crossrefType "journal-article" @default.
• W4384201712 hasAuthorship W4384201712A5016440729 @default.
• W4384201712 hasAuthorship W4384201712A5021273661 @default.
• W4384201712 hasAuthorship W4384201712A5022354072 @default.
• W4384201712 hasAuthorship W4384201712A5031324764 @default.
• W4384201712 hasAuthorship W4384201712A5045268154 @default.
• W4384201712 hasAuthorship W4384201712A5045592295 @default.
• W4384201712 hasAuthorship W4384201712A5046324935 @default.
• W4384201712 hasAuthorship W4384201712A5046960472 @default.
• W4384201712 hasAuthorship W4384201712A5057320214 @default.
• W4384201712 hasAuthorship W4384201712A5060665831 @default.
• W4384201712 hasAuthorship W4384201712A5061315225 @default.
• W4384201712 hasAuthorship W4384201712A5067397275 @default.
• W4384201712 hasAuthorship W4384201712A5075903251 @default.
• W4384201712 hasAuthorship W4384201712A5088874257 @default.
• W4384201712 hasAuthorship W4384201712A5090220659 @default.
• W4384201712 hasBestOaLocation W43842017121 @default.
• W4384201712 hasConcept C121608353 @default.
• W4384201712 hasConcept C126322002 @default.
• W4384201712 hasConcept C126838900 @default.
• W4384201712 hasConcept C143409427 @default.
• W4384201712 hasConcept C143998085 @default.
• W4384201712 hasConcept C185592680 @default.
• W4384201712 hasConcept C199374082 @default.
• W4384201712 hasConcept C2775842073 @default.
• W4384201712 hasConcept C2776256026 @default.
• W4384201712 hasConcept C2776297358 @default.
• W4384201712 hasConcept C2781197716 @default.
• W4384201712 hasConcept C2989005 @default.
• W4384201712 hasConcept C2993559085 @default.
• W4384201712 hasConcept C45664433 @default.
• W4384201712 hasConcept C55493867 @default.
• W4384201712 hasConcept C71924100 @default.
• W4384201712 hasConcept C80115893 @default.
• W4384201712 hasConceptScore W4384201712C121608353 @default.
• W4384201712 hasConceptScore W4384201712C126322002 @default.
• W4384201712 hasConceptScore W4384201712C126838900 @default.
• W4384201712 hasConceptScore W4384201712C143409427 @default.
• W4384201712 hasConceptScore W4384201712C143998085 @default.
• W4384201712 hasConceptScore W4384201712C185592680 @default.
• W4384201712 hasConceptScore W4384201712C199374082 @default.
• W4384201712 hasConceptScore W4384201712C2775842073 @default.
• W4384201712 hasConceptScore W4384201712C2776256026 @default.
• W4384201712 hasConceptScore W4384201712C2776297358 @default.
• W4384201712 hasConceptScore W4384201712C2781197716 @default.
• W4384201712 hasConceptScore W4384201712C2989005 @default.
• W4384201712 hasConceptScore W4384201712C2993559085 @default.
• W4384201712 hasConceptScore W4384201712C45664433 @default.
• W4384201712 hasConceptScore W4384201712C55493867 @default.
• W4384201712 hasConceptScore W4384201712C71924100 @default.
• W4384201712 hasConceptScore W4384201712C80115893 @default.
• W4384201712 hasIssue "14" @default.

• next